IGF2BP2 and type 2 diabetes mellitus: Integration of MPRA with caQTLs and eQTLs confirmed previously reported effects of the rs10428126 T2D risk allele, which increased reporter activity (Fig. 2b), in vivo chromatin accessibility (Fig. 2b), and IGF2BP2 expression in islets (Fig. 4a).